This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Madison, B. Articles by Ridderhof, J. Search for Related Content PubMed PubMed Citation Articles by Madison, B. Articles by Ridderhof, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2002, p. 3976-3979, Vol. 40, No. 11
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.11.3976-3979.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric Methods

B. Madison,^1* B. Robinson-Dunn,² I. George,³ W. Gross,⁴ H. Lipman,¹ B. Metchock,¹ A. Sloutsky,³ G. Washabaugh,⁵ G. Mazurek,¹ and J. Ridderhof¹

Centers for Disease Control and Prevention, Atlanta, Georgia,¹ Michigan Department of Community Health, Lansing, Michigan,² State Laboratory Institute, Boston, Massachusetts,³ Veterans Administration TB Reference Laboratory, West Haven, Connecticut,⁴ San Diego County Public Health Laboratory, San Diego, California⁵

Received 26 April 2002/ Returned for modification 3 July 2002/ Accepted 12 August 2002

Reproducibility of ethambutol (EMB) susceptibility test results for Mycobacterium tuberculosis has always been difficult for a variety of reasons, including the narrow range between the critical breakpoint for EMB resistance and the MIC for susceptible strains, borderline results obtained with the BACTEC 460TB method, the presence of microcolonies determined using the agar proportion (AP) method, and a lack of agreement between these two testing methods. To assess the frequency of these problems, M. tuberculosis drug susceptibility data were collected in a multicenter study involving four laboratories. Resistant, borderline, and susceptible isolates were shared among the laboratories to measure interlaboratory test agreement. Half of isolates determined by BACTEC 460TB to be resistant were determined to be susceptible by the AP method. Isolates determined to be resistant to EMB by both BACTEC 460TB and AP methods were almost always resistant to isoniazid. Results from isolates tested by the BACTEC 460TB method with an EMB concentration of 3.75 µg/ml in addition to the standard 2.5 µg/ml did not show improved agreement by the AP method. While these results do not indicate that the AP method is more accurate than the BACTEC 460TB method, laboratories should not report EMB monoresistance based on BACTEC 460TB results alone. Monoresistance to EMB should only be reported following confirmation by the AP method. Microcolonies could not be confirmed as resistant by the BACTEC 460TB method or by repeat testing with the AP method and do not appear to be indicative of resistance.

---

* Corresponding author. Mailing address: Centers for Disease Control and Prevention, 4770 Buford Highway, N.E., Mail Stop G-25, Atlanta, GA 30347. Phone: (770) 488-8133. Fax: (770) 488-8282. E-mail: bdm6{at}cdc.gov.

---

Journal of Clinical Microbiology, November 2002, p. 3976-3979, Vol. 40, No. 11
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.11.3976-3979.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Starks, A. M., Gumusboga, A., Plikaytis, B. B., Shinnick, T. M., Posey, J. E. (2009). Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53: 1061-1066 [Abstract] [Full Text]  
• Springer, B., Calligaris-Maibach, R. C., Ritter, C., Bottger, E. C. (2008). Tuberculosis Drug Resistance in an Area of Low Endemicity in 2004 to 2006: Semiquantitative Drug Susceptibility Testing and Genotyping. J. Clin. Microbiol. 46: 4064-4067 [Abstract] [Full Text]  
• Leonard, B., Coronel, J., Siedner, M., Grandjean, L., Caviedes, L., Navarro, P., Gilman, R. H., Moore, D. A. J. (2008). Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 46: 3526-3529 [Abstract] [Full Text]  
• Moore, D. A.J., Evans, C. A.W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Pinedo, Y., Saravia, J. C., Salazar, C., Oberhelman, R., Hollm-Delgado, M.-G., LaChira, D., Escombe, A. R., Friedland, J. S. (2006). Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB.. NEJM 355: 1539-1550 [Abstract] [Full Text]  
• Piersimoni, C., Olivieri, A., Benacchio, L., Scarparo, C. (2006). Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems. J. Clin. Microbiol. 44: 20-28 [Full Text]  
• Parsons, L. M., Salfinger, M., Clobridge, A., Dormandy, J., Mirabello, L., Polletta, V. L., Sanic, A., Sinyavskiy, O., Larsen, S. C., Driscoll, J., Zickas, G., Taber, H. W. (2005). Phenotypic and Molecular Characterization of Mycobacterium tuberculosis Isolates Resistant to both Isoniazid and Ethambutol. Antimicrob. Agents Chemother. 49: 2218-2225 [Abstract] [Full Text]  
• Moore, D. A. J., Mendoza, D., Gilman, R. H, Evans, C. A. W., Hollm Delgado, M.-G., Guerra, J., Caviedes, L., Vargas, D., Ticona, E., Ortiz, J., Soto, G., Serpa, J., the Tuberculosis Working Group in Peru, (2004). Microscopic Observation Drug Susceptibility Assay, a Rapid, Reliable Diagnostic Test for Multidrug-Resistant Tuberculosis Suitable for Use in Resource-Poor Settings. J. Clin. Microbiol. 42: 4432-4437 [Abstract] [Full Text]